EFM
BLUE

E Fund Management’s bluebird bio BLUE Stock Holding History

E Fund Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,503
Closed -$96.7K – 372
2023
Q4 		$96.7K Buy
3,503
+154
+5% +$9.39K 0.01% 301
2023
Q3 		$204K Sell
3,349
-1,081
-24% -$75.9K 0.02% 257
2023
Q2 		$291K Sell
4,430
-177
-4% -$12.9K 0.02% 223
2023
Q1 		$293K Buy
4,607
+1,785
+63% +$204K 0.02% 228
2022
Q4 		$391K Sell
2,822
-514
-15% -$72.4K 0.03% 186
2022
Q3 		$422K Buy
+3,336
New +$377K 0.04% 168
2022
Q2 		– Sell
-2,456
Closed -$238K – 330
2022
Q1 		$238K Buy
2,456
+1,488
+154% +$196K 0.01% 263
2021
Q4 		$193K Buy
+968
New +$228K 0.01% 268

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

E Fund Management's BLUE Position: Q1 2024 in Review

E Fund Management sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 3,503 shares — an estimated $96.7K sold.

E Fund Management first reported a position in BLUE in Q4 2021 and held it in 8 quarters. The position peaked at $422K in Q3 2022. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • E Fund Management reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • E Fund Management sold 3,503 bluebird bio shares in Q1 2024, an estimated $96.7K.
  • E Fund Management first reported a position in bluebird bio in Q4 2021 and held it in 8 quarters.
  • E Fund Management's bluebird bio position peaked at $422K in Q3 2022.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on E Fund Management's 13F filing for Q1 2024, filed 13 May 2024.